Abstract
A new series of N'-substituted benzylidene-2-(4-oxo-2-phenyl-1,4-dihydroquinazolin-3(2H)-yl)acetohydrazide (5a-5h) has been synthesized, characterized by FT-IR, NMR spectroscopy and mass spectrometry and tested against human monoamine oxidase (MAO) A and B. Only (3-methoxy-4-hydroxy)benzoyl substituted compounds gave submicromolar inhibition of MAO-A and MAO-B. Changing the phenyl substituent to methyl on the unsaturated quinazoline ring (12a-12d) decreased inhibition but a less flexible linker (14a-14d) resulted in selective micromolar inhibition of hMAO B providing insight for ongoing design.
Original language | English |
---|---|
Article number | 200050 |
Number of pages | 18 |
Journal | Royal Society Open Science |
Volume | 7 |
DOIs | |
Publication status | Published - 22 Apr 2020 |
Keywords
- Structure-activity relationships
- Quinazoline analogues
- Antidepressant
- Monoamine oxidase inhibitors